UF researchers help lead international studies into two rare neuromuscular disorders October 12, 2020
Chondrial Therapeutics Announces First Dosing in CTI-1601 for Treatment of Friedreich’s Ataxia December 18, 2019
Reata Pharmaceuticals Reacquires Rights From AbbVie to Develop and Commercialize Next-Generation Nrf2 Activators October 10, 2019